Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Ramping up production, very positive sign

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Mar 18, 2024 6:51pm

117 Views

Post# 35939350

RE:RE:Ramping up production, very positive sign

Hahaha your posts are my new favorite thing to read on this, or any other site. I give it a 17% chance that you have ever been intimate with a female. 95% chance that you dont own a single share in this company and 100% you have zero idea or insight on just about anything.

Where is Quentin? He's been getting rekt the last week or so, he's usually on supporting your drivel! Been a rough one for him Bro? Come back Quentin, just Hodl bro, diamond hands bro!

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant